Dr. Deborah E Farr, MD
Claim this profileUT Southwestern Medical Center
Studies Breast Cancer
Studies Risk for Developing Breast Cancer
2 reported clinical trials
2 drugs studied
Area of expertise
1Breast Cancer
Stage II
Stage I
2Risk For Developing Breast Cancer
Affiliated Hospitals
Clinical Trials Deborah E Farr, MD is currently running
Fluorescence Imaging
for Breast Cancer Surgery
The investigators' preclinical data have demonstrated the feasibility of fluorescence-guided tumor resection by Cancer Vision Goggles (CVG) with LS301 in animal models. In this study, the investigators will conduct intraoperative imaging procedures that have minimal interference with ongoing surgery. The underlying hypothesis is that the accurate detection of all cancer cells highlighted by LS301 during surgery will reduce the number of breast cancer patients with margin positivity to less than 5%, compared to the current surgical paradigm of greater than 20%. The pilot study will obtain critical data required to address the larger question of surgical margin assessment in a full Phase I clinical trial. Phase 1: to determine the safety and optimal imaging dose of LS301 injected in breast cancer patients. Phase 2: to determine the ability of this novel fluorescence imaging agent to predict the presence of positive margins around partial mastectomy specimens and positive SLNs during surgical therapy for breast cancer.
Recruiting1 award Phase 1 & 24 criteria
Robotic Nipple-Sparing Mastectomy
for Breast Cancer
This trial uses a robotic system to perform nipple-sparing mastectomy and immediate breast reconstruction. It targets patients with breast cancer or those at high risk. The robot allows precise surgery through a small incision, potentially improving recovery and satisfaction. The robotic system has been used for this type of surgery since its introduction, showing favorable outcomes in terms of cosmetic results and patient satisfaction.
Recruiting1 award N/A2 criteria
More about Deborah E Farr, MD
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Deborah E Farr, MD has experience with
- Robotic SP Nipple Sparing Mastectomy
- LS301
Breakdown of trials Deborah E Farr, MD has run
Breast Cancer
Risk for Developing Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah E Farr, MD specialize in?
Deborah E Farr, MD focuses on Breast Cancer and Risk for Developing Breast Cancer. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage I.
Is Deborah E Farr, MD currently recruiting for clinical trials?
Yes, Deborah E Farr, MD is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Deborah E Farr, MD has studied deeply?
Yes, Deborah E Farr, MD has studied treatments such as Robotic SP Nipple Sparing Mastectomy, LS301.
What is the best way to schedule an appointment with Deborah E Farr, MD?
Apply for one of the trials that Deborah E Farr, MD is conducting.
What is the office address of Deborah E Farr, MD?
The office of Deborah E Farr, MD is located at: UT Southwestern Medical Center, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.